147 related articles for article (PubMed ID: 20740587)
1. Aspirin and compression devices versus low-molecular-weight heparin and PCD for VTE prophylaxis in orthopedic oncology patients.
Patel AR; Crist MK; Nemitz J; Mayerson JL
J Surg Oncol; 2010 Sep; 102(3):276-81. PubMed ID: 20740587
[TBL] [Abstract][Full Text] [Related]
2. A mobile compression device compared with low-molecular-weight heparin for prevention of venous thromboembolism in total hip arthroplasty.
Hardwick ME; Pulido PA; Colwell CW
Orthop Nurs; 2011; 30(5):312-6. PubMed ID: 21934585
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].
Tian H; Song F; Zhang K; Liu Y
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3349-52. PubMed ID: 18478950
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism prophylaxis after major orthopaedic surgery: a pooled analysis of randomized controlled trials.
Brown GA
J Arthroplasty; 2009 Sep; 24(6 Suppl):77-83. PubMed ID: 19628366
[TBL] [Abstract][Full Text] [Related]
6. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
7. Evolution of Prophylaxis Protocols for Venous Thromboembolism in Neurosurgery: Results from a Prospective Comparative Study on Low-Molecular-Weight Heparin, Elastic Stockings, and Intermittent Pneumatic Compression Devices.
Chibbaro S; Cebula H; Todeschi J; Fricia M; Vigouroux D; Abid H; Kourbanhoussen H; Pop R; Nannavecchia B; Gubian A; Prisco L; Ligarotti GKI; Proust F; Ganau M
World Neurosurg; 2018 Jan; 109():e510-e516. PubMed ID: 29033376
[TBL] [Abstract][Full Text] [Related]
8. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolic disease reduction with a portable pneumatic compression device.
Froimson MI; Murray TG; Fazekas AF
J Arthroplasty; 2009 Feb; 24(2):310-6. PubMed ID: 18534456
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
11. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
12. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
Ennis RS
J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
[TBL] [Abstract][Full Text] [Related]
13. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
Tapson VF; Hull RD
Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540
[TBL] [Abstract][Full Text] [Related]
14. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
Asopa V; Cobain W; Martin D; Keene G; Bauze A
ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
[TBL] [Abstract][Full Text] [Related]
15. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery.
Epstein NE
Surg Neurol; 2005 Oct; 64(4):295-301; discussion 302. PubMed ID: 16181995
[TBL] [Abstract][Full Text] [Related]
16. Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty.
Gonzalez Della Valle A; Shanaghan KA; Nguyen J; Liu J; Memtsoudis S; Sharrock NE; Salvati EA
Bone Joint J; 2020 Jul; 102-B(7_Supple_B):71-77. PubMed ID: 32600195
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
[TBL] [Abstract][Full Text] [Related]
18. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry.
Jameson SS; Charman SC; Gregg PJ; Reed MR; van der Meulen JH
J Bone Joint Surg Br; 2011 Nov; 93(11):1465-70. PubMed ID: 22058295
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolic prophylaxis in head trauma and multiple-trauma patients.
Latronico N; Berardino M
Minerva Anestesiol; 2008 Oct; 74(10):543-8. PubMed ID: 18475247
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effectiveness and safety of bemiparin in a large population of orthopedic patients in a normal clinical practice.
Otero-Fernández R; Gómez-Outes A; Martínez-González J; Rocha E; Fontcuberta J;
Clin Appl Thromb Hemost; 2008 Jan; 14(1):75-83. PubMed ID: 17895506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]